We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-0.8%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$34.9B
AUM Growth
-$1.13B
(-3.1%)
Cap. Flow
+$285M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,759
New
116
Increased
900
Reduced
520
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$508M |
| 2 |
Walmart Inc
WMT
|
+$217M |
| 3 |
Qualcomm
QCOM
|
+$129M |
| 4 |
Procter & Gamble
PG
|
+$116M |
| 5 |
Abbott
ABT
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$485M |
| 2 |
TSMC
TSM
|
+$384M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$275M |
| 4 |
ASML
ASML
|
+$209M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.54% |
| 2 | Communication Services | 10.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Healthcare | 6.97% |
| 5 | Financials | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UPB
1401
Upstream Bio Inc
UPB
$381M
| $25.4K | ﹤0.01% |
2,819
+193
| +7% | +$3.47K |
|
1402
Entrada Therapeutics
TRDA
$291M
| $25.2K | ﹤0.01% |
1,997
+140
| +8% | +$1.6K |
|
1403
4D Molecular Therapeutics
FDMT
$612M
| $24.8K | ﹤0.01% |
2,661
-115
| -4% | -$1K |
|
1404
Dynatrace
DT
$14B
| $24.5K | ﹤0.01% |
662
-44,061
| -99% | -$1.68M |
|
1405
Ally Financial
ALLY
$13.5B
| $24.4K | ﹤0.01% |
622
-15
| -2% | -$617 |
|
|
UMH
1406
UMH Properties
UMH
$1.41B
| $24.1K | ﹤0.01% |
1,667
-691
| -29% | -$10.7K |
|
1407
Aclaris Therapeutics
ACRS
$889M
| $23.6K | ﹤0.01% |
6,290
+1,025
| +19% | +$3.46K |
|
1408
Absci
ABSI
$1.61B
| $23.5K | ﹤0.01% |
7,843
+536
| +7% | +$1.55K |
|
|
DHC
1409
Diversified Healthcare Trust
DHC
$2.02B
| $23.2K | ﹤0.01% |
3,490
-1,449
| -29% | -$9.19K |
|
1410
Cartesian Therapeutics
RNAC
$267M
| $22.8K | ﹤0.01% |
+3,715
| New | +$26.5K |
|
1411
Envista
NVST
$4.49B
| $22.6K | ﹤0.01% |
+892
| New | +$23.1K |
|
1412
monday.com
MNDY
$3.62B
| $22.6K | ﹤0.01% |
327
+24
| +8% | +$2.3K |
|
1413
Lyell Immunopharma
LYEL
$344M
| $22.2K | ﹤0.01% |
1,108
+77
| +7% | +$1.8K |
|
1414
Aura Biosciences
AURA
$808M
| $22.2K | ﹤0.01% |
3,312
+226
| +7% | +$1.3K |
|
1415
Regenxbio
RGNX
$711M
| $22.1K | ﹤0.01% |
2,640
+180
| +7% | +$1.89K |
|
1416
Atea Pharmaceuticals
AVIR
$419M
| $21.9K | ﹤0.01% |
4,075
+279
| +7% | +$1.28K |
|
1417
Lexeo Therapeutics
LXEO
$400M
| $21.9K | ﹤0.01% |
3,807
+260
| +7% | +$1.84K |
|
1418
Maravai LifeSciences
MRVI
$869M
| $21.6K | ﹤0.01% |
7,635
+588
| +8% | +$1.99K |
|
1419
Liberty Live Group Series A
LLYVA
$9.58B
| $21.4K | ﹤0.01% |
233
+171
| +276% | +$15K |
|
1420
Vanda Pharmaceuticals
VNDA
$307M
| $21.3K | ﹤0.01% |
3,083
+211
| +7% | +$1.63K |
|
1421
Thor Industries
THO
$4.11B
| $21.3K | ﹤0.01% |
266
-108
| -29% | -$11K |
|
1422
Icon
ICLR
$12.8B
| $21.1K | ﹤0.01% |
191
+5
| +3% | +$683 |
|
|
FINV
1423
FinVolution Group
FINV
$1.06B
| $20.9K | ﹤0.01% |
4,356
+39
| +0.9% | +$207 |
|
1424
Pacific Biosciences
PACB
$351M
| $20.8K | ﹤0.01% |
15,752
+1,081
| +7% | +$1.93K |
|
1425
RLJ Lodging Trust
RLJ
$1.67B
| $20.8K | ﹤0.01% |
2,802
-1,175
| -30% | -$9.14K |
|
Similar funds
Mirae Asset Global Investments's Q1 2026 Portfolio in Review
As of Q1 2026, Mirae Asset Global Investments held 1,759 positions worth $34.9B, down 3.1% from $36B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mirae Asset Global Investments's Q1 2026 filing shows 116 new, 900 increased, 520 reduced and 190 closed positions. Its largest new stake was Vanguard Energy ETF: 221,700 shares worth $38.4M. The largest sale was Alphabet (Google) Class C, an estimated $485M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Mirae Asset Global Investments's largest Q1 2026 buy was Vanguard Energy ETF: 221,700 shares worth $38.4M.
- Mirae Asset Global Investments added most to Alphabet (Google) Class A in Q1 2026, an estimated $508M increase.
- Mirae Asset Global Investments's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $485M.
- Mirae Asset Global Investments fully exited Vanguard Morningstar Mega Cap Growth ETF in Q1 2026, selling an estimated $25.4M.
- Mirae Asset Global Investments's ten largest holdings make up 36% of its $34.9B portfolio in Q1 2026.
- Mirae Asset Global Investments opened 116 new positions and closed 190 in Q1 2026.
- Mirae Asset Global Investments's portfolio value fell 3.1% quarter-over-quarter to $34.9B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.